Chronic Pain Clinical Trial
Official title:
MUSic Therapy to Improve Quality Of Life in Sickle Cell Disease (MUSIQOLS): A Pilot Study
Verified date | May 2019 |
Source | University Hospitals Cleveland Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this pilot study is to investigate the effects of a 6-session music therapy protocol on the pain, mood, quality of life, coping skills, and self-efficacy of adult patients with sickle cell disease (SCD) as compared to adult patients with SCD who receive standard care alone. The investigators will also determine the feasibility (delivery, acceptability, and usefulness) of the music therapy intervention for pain management and quality of life.
Status | Completed |
Enrollment | 24 |
Est. completion date | December 30, 2018 |
Est. primary completion date | December 30, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Subject is 18 years or older - Subject has a SCD diagnosis - Subject fits chronic pain criteria in SCD - Subject has a working email address - Subject has access to a mobile device with email and internet capabilities - Subject is able to speak and understand English - Subject has attended at least 50% of his/her scheduled outpatient visits to the Adult SCD Clinic in the last 12 months Exclusion Criteria: - Subject has a significant visual impairment that has not been corrected - Subject has a significant hearing impairment that has not been corrected - Subject has a significant cognitive impairment that would prevent subject from participating in the study |
Country | Name | City | State |
---|---|---|---|
United States | University Hospitals Seidman Cancer Center | Cleveland | Ohio |
Lead Sponsor | Collaborator |
---|---|
University Hospitals Cleveland Medical Center | Kulas Foundation |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Semi-structured interview | Interview questions will focus on the patient's current pain, his/her experience of the music therapy sessions, and whether anything could have been done differently to improve the music therapy sessions. | At post-test at 10 weeks | |
Primary | Change from baseline in Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function Short Form 4a | Physical function (4 questions) | Pre-test at baseline and post-test at 10 weeks | |
Primary | Change from baseline in Adult Sickle Cell Quality of Life Measurement Information System (ASCQ-Me) | A patient-reported outcome measurement system that addresses the physical, social, and emotional impact of SCD. ASCQ-Me scores are calculated in the direction of overall health, with higher ASCQ-Me scores indicating better health. | Pre-test at baseline and post-test at 10 weeks | |
Primary | Change from baseline in Patient-Reported Outcomes Measurement Information System (PROMIS) Emotional Distress-Anxiety Short Form 4a | Anxiety (4 questions) | Pre-test at baseline and post-test at 10 weeks | |
Primary | Change from baseline in Patient-Reported Outcomes Measurement Information System (PROMIS) Emotional Distress-Depression - Short Form 4a | Depression (4 questions) | Pre-test at baseline and post-test at 10 weeks | |
Primary | Change from baseline in Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue - Short Form 4a | Fatigue (4 questions) | Pre-test at baseline and post-test at 10 weeks | |
Primary | Change from baseline in Patient-Reported Outcomes Measurement Information System (PROMIS) Ability to Participate in Social Roles and Activities - Short Form 4a | Ability to participate in social roles and activities (4 questions) | Pre-test at baseline and post-test at 10 weeks | |
Primary | Change from baseline in Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference - Short Form 4a | Pain interference (4 questions) | Pre-test at baseline and post-test at 10 weeks | |
Secondary | Change from baseline in Sickle Cell Self-Efficacy Scale (SCSES) | A nine-item Likert scale originally developed for adults with SCD to assess patients' beliefs in their ability to manage their own SCD. | Pre-test at baseline and post-test at 10 weeks | |
Secondary | Change from baseline in Coping Skills Questionnaire - Sickle Cell Disease (CSQ-SCD) | 80-item questionnaire that assesses coping strategies relevant to SCD | Pre-test at baseline and post-test at 10 weeks | |
Secondary | Electronic Sickle Cell Disease Pain Diary | A multidimensional pain diary assessing daily pain intensity, location, description, cause, and interference with daily activities | Daily entries for 2 weeks at baseline and daily entries for 2 weeks post-intervention | |
Secondary | Change from baseline in Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance - Short Form 4a | Sleep disturbance (4 questions) | Pre-test at baseline and post-test at 10 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01659073 -
Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation
|
N/A | |
Recruiting |
NCT05914311 -
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
|
N/A | |
Recruiting |
NCT05422456 -
The Turkish Version of Functional Disability Inventory
|
||
Enrolling by invitation |
NCT05422443 -
The Turkish Version of Pain Coping Questionnaire
|
||
Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
Completed |
NCT04385030 -
Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
|
N/A | |
Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
Completed |
NCT05103319 -
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
|
||
Completed |
NCT03687762 -
Back on Track to Healthy Living Study
|
N/A | |
Completed |
NCT04171336 -
Animal-assisted Therapy for Children and Adolescents With Chronic Pain
|
N/A | |
Completed |
NCT03179475 -
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
|
Phase 4 | |
Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
Recruiting |
NCT06204627 -
TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain
|
N/A | |
Recruiting |
NCT06060028 -
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
|
N/A | |
Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
Not yet recruiting |
NCT05812703 -
Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
|